Sage Therapeutics Inc.

NASDAQ: SAGE · Real-Time Price · USD
8.68
0.00 (0.00%)
At close: Jul 30, 2025, 3:59 PM

Sage Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-400.67M -541.49M -532.78M -457.89M
Depreciation & Amortization
-5.45M 1.39M 1.12M 4.18M
Stock-Based Compensation
54.5M 73.37M 61.6M 104.63M
Other Working Capital
8.51M -58.89M -2.76M -6.69M
Other Non-Cash Items
-344K -6.47M 4.35M -10.6M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
84.76M -67.38M 5.67M -18.51M
Operating Cash Flow
-267.19M -540.59M -460.04M -378.18M
Capital Expenditures
n/a -553K -937K -372K
Cash Acquisitions
n/a n/a -326.37M 1B
Purchase of Investments
-450.96M -594.67M -881.04M -1.99B
Sales Maturities Of Investments
717.63M 1.04B 1.21B 988.08M
Other Investing Acitivies
n/a n/a 326.37M -1B
Investing Cash Flow
266.68M 442.91M 325.43M -1B
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -903K -43K -1.39M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.5M 6.03M 3.07M 13.33M
Financial Cash Flow
10.66M 6.03M 3.07M 13.33M
Net Cash Flow
10.15M -91.64M -131.53M -1.37B
Free Cash Flow
-267.19M -541.14M -460.97M -378.55M